Search research articles
Contact Us
Filters
Showing results (11-20 of 62) with videos related to
Page
of 7
Sort By:
Transplantation and Cellular Therapy
|
September 4, 2021
Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center Experience
Kuo-Kai Chin, Haesook T Kim, Eno-Abasi Inyang, et al.
Blood Advances
|
April 19, 2022
Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis
Mahasweta Gooptu, Haesook T Kim, Eric Jacobsen, et al.
Transplantation and Cellular Therapy
|
May 4, 2024
Comparison of Older Related versus Younger Unrelated Donors for Older Recipients of Allogeneic Hematopoietic Cell Transplantation with Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Large Single-Center Analysis
Haesook T Kim, Vincent T Ho, Sarah Nikiforow, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
April 18, 2021
Cytomegalovirus events in high-risk allogeneic hematopoietic-cell transplantation patients who received letermovir prophylaxis
Kaiwen Chen, Esther Arbona-Haddad, Matthew P Cheng, et al.
Haematologica
|
April 10, 2025
Reduced incidence of relapse and graft-<i>versus</i>-host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantation
Haesook T Kim, Robert J Soiffer, Corey Cutler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 21, 2018
A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis
Mahasweta Gooptu, Haesook T Kim, Vincent T Ho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2022
Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for <i>TP53</i>-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes
Asmita Mishra, Roni Tamari, Amy E DeZern, et al.
Blood Advances
|
May 8, 2023
Posttransplant cyclophosphamide vs tacrolimus-based GVHD prophylaxis: lower incidence of relapse and chronic GVHD
Katie Maurer, Vincent T Ho, Eno Inyang, et al.
Transplantation and Cellular Therapy
|
May 4, 2021
Efficacy and Safety of 1% Progesterone Gel to the Forehead for Ocular Chronic Graft-versus-Host Disease
Zhonghui K Luo, Edgar A Domenech-Estarellas, Amy Han, et al.
Blood Advances
|
May 22, 2023
Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse
Roman M Shapiro, Haesook T Kim, Michela Ansuinelli, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 62) with videos related to
Sort By:
Page
of 7
Transplantation and Cellular Therapy
|
September 4, 2021
Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center Experience
Kuo-Kai Chin, Haesook T Kim, Eno-Abasi Inyang, et al.
Blood Advances
|
April 19, 2022
Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis
Mahasweta Gooptu, Haesook T Kim, Eric Jacobsen, et al.
Transplantation and Cellular Therapy
|
May 4, 2024
Comparison of Older Related versus Younger Unrelated Donors for Older Recipients of Allogeneic Hematopoietic Cell Transplantation with Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Large Single-Center Analysis
Haesook T Kim, Vincent T Ho, Sarah Nikiforow, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
April 18, 2021
Cytomegalovirus events in high-risk allogeneic hematopoietic-cell transplantation patients who received letermovir prophylaxis
Kaiwen Chen, Esther Arbona-Haddad, Matthew P Cheng, et al.
Haematologica
|
April 10, 2025
Reduced incidence of relapse and graft-<i>versus</i>-host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantation
Haesook T Kim, Robert J Soiffer, Corey Cutler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 21, 2018
A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis
Mahasweta Gooptu, Haesook T Kim, Vincent T Ho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2022
Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for <i>TP53</i>-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes
Asmita Mishra, Roni Tamari, Amy E DeZern, et al.
Blood Advances
|
May 8, 2023
Posttransplant cyclophosphamide vs tacrolimus-based GVHD prophylaxis: lower incidence of relapse and chronic GVHD
Katie Maurer, Vincent T Ho, Eno Inyang, et al.
Transplantation and Cellular Therapy
|
May 4, 2021
Efficacy and Safety of 1% Progesterone Gel to the Forehead for Ocular Chronic Graft-versus-Host Disease
Zhonghui K Luo, Edgar A Domenech-Estarellas, Amy Han, et al.
Blood Advances
|
May 22, 2023
Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse
Roman M Shapiro, Haesook T Kim, Michela Ansuinelli, et al.
Page
of 7